The global in-vitro diagnostics market is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025.
The global in-vitro diagnostics market size is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025. The demand for in-vitro diagnostic products due to the COVID-19 pandemic is expected to increase mainly due to factors such as a sharp rise in market demand for PCR, NGS, serology based rapid-test products, the supportive regulatory landscape for product development & commercialization, and a sharp rise in target patient population. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities as well as to focus on product commercialization & upgrades. The in-vitro diagnostics market is segmented on technology, end user, and region/country.
The PCR segment is expected to hold the largest share of the market in 2020 H1. Based on technology, the in-vitro diagnostics market is segmented into PCR, NGS, ELISA, Rapid-tests, clinical chemistry, hematology, hemostasis, urinalysis, microbiology testing, and others.The PCR segment is expected to hold the largest share of the global in-vitro diagnostics industry in 2020 – H1.
Factors such as the increasing patient emphasis on effective & early patient screening, continued commercialization of novel COVID screening platforms by major players, early efforts of key players to address supply chain bottlenecks, and easy availability of controls & standards are driving the growth of this segment.
US to account for the largest share of the in-vitro diagnostics industry in 2020 H1. The US is expected to account for the largest share of the in-vitro diagnostics market in 2020 - H1, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative diagnostic products coupled with ongoing advancements in the field of gene & immunoassay based products, the recent discovery of genetic biomarkers & their clinical role in immunoassay testing, supportive government policies & their emphasis on novel product development, and the significant expansion of target patient population.
Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (45%), Tier 2 (34%), and Tier 3 (21%) • By Designation: C-level (47%), Director-level (33%), and Others (20%) • By Region: North America (35%), Europe (32%), APAC (25%), Latin America (6%), and MEA (2%)
As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.
Research Coverage This report studies the in-vitro diagnostics market based on technology, end user, and region/country.It studies major factors (such as drivers and restraints) affecting the market growth.
The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for global leaders.It analyzes micromarkets with respect to individual growth trends, prospects, and contributions to the total market.
The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.
Key Benefits of Buying the Report This report focuses on various levels of analysis — industry trends, COVID impact on major technologies, market shares of major global players, which together form basic views.It also analyzes the competitive landscape; major & emerging segments of the in-vitro diagnostics market; and high-growth geographies and their drivers, restraints, challenges, and opportunities.
The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Our reports have been used by over 10K customers, including:
The in-vitro diagnostics market in Middle East and Africa is expected to grow from US$ 2,675.1 million in 2019 to US$ 3,454.0 million by 2027; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. Diabetes in adults generates higher risk of functional...
The global in-vitro diagnostics market is expected to reach US$ 90,656.80 million by 2027 from US$ 63,746.63 million in 2019. The market is estimated to grow at a CAGR of 4.5% from 2020 to 2027. The in-vitro diagnostics market has accounted for a significant market share in the global healthcare industry during the COVID-19 pandemic.The...
The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices. By...
94 pages •
By Asia Market Information & Development Company
• Sep 2020
This study focuses on China’s In Vitro Diagnostics industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...
The global IVD quality control market is projected to grow at a CAGR of 3.8%. The global IVD quality control market size is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. The market for IVD quality control is primarily driven by the increasing number of accredited...
The India household insecticides market is accounted to US$ 1,147.5 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 - 2027, to account for US$ 1,829.6 Mn by 2027. The household insecticides market has been witnessing a remarkable growth in India from the last few years. Household insecticide products are...
Global Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review
$15,900SummaryThis comprehensive seven-country report...
ADME Toxicology (Absorption, Distribution, Metabolism And Elimination)Testing Market Size, Outlook and Growth Opportunities, 2019- 2025 Global ADME Toxicology Testing Market Size, Outlook and Growth Opportunities to 2025: By Product Type (Software Solutions, Assays Systems, Reagents, and Others), By Technology Type...
In Vitro Diagnostics (IVD) Market Size, Outlook and Growth Opportunities, 2019- 2025 Global In Vitro Diagnostics (IVD) Market Size, Outlook and Growth Opportunities to 2025: By Technique (Histochemistry, Molecular Diagnostics, Hematology, POC Testing, Self-blood Glucose Testing, Immunochemistry, and Others), By Product...
Nanomedicine Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Nanomedicine Market size, Outlook and Opportunities 2019- 2025: By Modality (Treatments and Diagnostics), By Product (Therapeutics, In-vivo diagnostics, In-vitro diagnostics, Vaccines and Regenerative medicine), By Application (Clinical Oncology,...
In Vitro Diagnostics
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.